The Academy of Translational Medicine is pleased to announce that $3,137,050 in funding from the CIHR Project Grant: Fall 2023 competition has been awarded to 4 projects whose principal investigators are part of the ATM Community.
These 4 projects represent 9% of the 46 successful projects led by UBC Faculty of Medicine researchers (the 46 projects totalled $31.3M), with 3 projects being Project Grants, and 1 being a Priority Announcement. Of the 4 successful grants, 1 was awarded to Director of the ATM Dr. Poul Sorensen, and 3 were awarded to ATM Faculty Members Dr. Zachary Laksman, Dr. Dena Shahriari, and Dr. Emily Brigham.
Dr. Poul Sorensen, Director of the Academy of Translational Medicine, shares the following message:
“I am delighted to see that a number of successful CIHR applications in the most recent competition were awarded to ATM Members. By spearheading pioneering biomedical research, the ATM Community continues to spearhead transformative advancements, with the promise to deliver significant benefits to patients in the future, while elevating the threshold for innovation emerging from the ATM.”
ATM-led Projects
Dr. Poul Sorensen (ATM Director)
- Project: Targeting metabolic vulnerabilities in childhood cancers using immunotherapy
- Funding: $956,250
- Term: 5 years
Emily Brigham (ATM Member)
- Project: Health Effects of Wood Smoke and Traffic-Related Air Pollution Exposures: A Necessary Comparison (Priority Announcement: Health and Climate Change)
- Funding: $100,000
- Term: 1 year
Dr. Zachary Laksman (ATM Member)
- Project: Personalized drug safety and targeted drug therapies for individuals with truncating titin variants
- Funding: $1,124,550
- Term: 5 years
Dr. Dena Shahriari (ATM Member)
- Project: Optogenetic stimulation after spinal cord injury in rodents
- Funding: $956,250
- Term: 5 years
The Project Grant: Fall 2023 competition awarded a cumulative 374 research grants plus 6 bridge grants (~$325M total), 150 priority announcement grants (~$16.4M total) and 14 supplemental prizes ($450k total).
Full announcements: